Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemifloxacin vs Ciprofloxacin vs Rifampicin in Rhinoscleroma
NCT03326050Phase 1Unknown
- Sponsor
- Assiut University
- Start
- Feb 2018
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of gemifloxacin in Rhinoscleroma (3 arms), sponsored by Assiut University. Primary endpoints: Clinical examination of nasal crustation at 6 months, Clinical examination of purulent secretions at 6 months and 1 more. Status: unknown.
02
Drugs
gemifloxacin
03
Conditions
Rhinoscleroma
Beyond the preview
Go deeper on NCT03326050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03326050.